Article
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia.
Blood cancer journal - 19 Jan 2018
Johansson Patricia, Klein-Hitpass Ludger, Choidas Axel, Habenberger Peter, Mahboubi Bijan, Kim Baek, Bergmann Anke, Scholtysik René, Brauser Martina, Lollies Anna, Siebert Reiner, Zenz Thorsten, Dührsen Ulrich, Küppers Ralf, Dürig Jan
Abstract excerpt
T-cell prolymphocytic leukemia (T-PLL) is an aggressive malignancy with a median survival of the patients of less than two years. Besides characteristic chromosomal translocations, frequent mutations affect the ATM gene, JAK/STAT pathway members, and epigenetic regulators. We here performed a targeted mutation analysis for 40 genes selected from a RNA sequencing of 10 T-PLL in a collection of 28 T-PLL, and an...
Topics
Join the communities discussing this publication.
